Resolute Advisors’s HCA Healthcare HCA Stock Holding History

Resolute Advisors’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-59	Closed	-$14K	–	335
2021 Q3	$14K	Hold	59	–	–	﹤0.01%	273
2021 Q2	$12K	Hold	59	–	–	﹤0.01%	251
2021 Q1	$4K	Buy	+59	New	+$10.4K	﹤0.01%	360

Other funds holding HCA

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Resolute Advisors's HCA Position: Q4 2021 in Review

Resolute Advisors sold out of HCA Healthcare (HCA) in Q4 2021, closing a stake of 59 shares — an estimated $14K sold.

Resolute Advisors first reported a position in HCA in Q1 2021 and held it in 3 quarters. The position peaked at $14K in Q3 2021. 947 funds tracked by Wall St. Rank hold HCA as of Q4 2021.

Resolute Advisors reported no remaining HCA Healthcare position as of Q4 2021 after selling out during the quarter.
Resolute Advisors sold 59 HCA Healthcare shares in Q4 2021, an estimated $14K.
Resolute Advisors first reported a position in HCA Healthcare in Q1 2021 and held it in 3 quarters.
Resolute Advisors's HCA Healthcare position peaked at $14K in Q3 2021.
947 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2021.

Based on Resolute Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.